Guggenheim Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.88M | Sell |
22,924
-1,355
| -6% | -$170K | 0.02% | 548 |
|
|
2025
Q1 | $2.69M | Buy |
24,279
+1,381
| +6% | +$153K | 0.02% | 561 |
|
|
2024
Q4 | $3.13M | Sell |
22,898
-9,134
| -29% | -$1.25M | 0.03% | 530 |
|
|
2024
Q3 | $3.69M | Sell |
32,032
-18,115
| -36% | -$2.09M | 0.03% | 624 |
|
|
2024
Q2 | $6.9M | Buy |
50,147
+12,629
| +34% | +$1.74M | 0.05% | 418 |
|
|
2024
Q1 | $5.17M | Buy |
37,518
+8,579
| +30% | +$1.18M | 0.04% | 541 |
|
|
2023
Q4 | $3.81M | Sell |
28,939
-10,169
| -26% | -$1.34M | 0.03% | 615 |
|
|
2023
Q3 | $4.4M | Sell |
39,108
-5,188
| -12% | -$584K | 0.04% | 529 |
|
|
2023
Q2 | $4.18M | Buy |
44,296
+2,415
| +6% | +$228K | 0.03% | 585 |
|
|
2023
Q1 | $4.24M | Sell |
41,881
-265
| -0.6% | -$26.8K | 0.04% | 574 |
|
|
2022
Q4 | $5.03M | Sell |
42,146
-1,351
| -3% | -$161K | 0.04% | 521 |
|
|
2022
Q3 | $4.62M | Sell |
43,497
-3,782
| -8% | -$402K | 0.04% | 529 |
|
|
2022
Q2 | $4.61M | Sell |
47,279
-10,003
| -17% | -$975K | 0.04% | 576 |
|
|
2022
Q1 | $5.37M | Sell |
57,282
-4,900
| -8% | -$459K | 0.03% | 620 |
|
|
2021
Q4 | $5.3M | Buy |
62,182
+3,449
| +6% | +$294K | 0.03% | 661 |
|
|
2021
Q3 | $5.63M | Sell |
58,733
-1,322
| -2% | -$127K | 0.03% | 610 |
|
|
2021
Q2 | $5.85M | Buy |
60,055
+9,106
| +18% | +$886K | 0.03% | 613 |
|
|
2021
Q1 | $4.96M | Buy |
50,949
+12,056
| +31% | +$1.17M | 0.03% | 629 |
|
|
2020
Q4 | $3.73M | Buy |
38,893
+352
| +0.9% | +$33.7K | 0.02% | 712 |
|
|
2020
Q3 | $3.71M | Sell |
38,541
-5,981
| -13% | -$575K | 0.03% | 645 |
|
|
2020
Q2 | $5.43M | Buy |
44,522
+4,185
| +10% | +$511K | 0.04% | 487 |
|
|
2020
Q1 | $3.49M | Sell |
40,337
-8,860
| -18% | -$767K | 0.04% | 585 |
|
|
2019
Q4 | $5.29M | Buy |
49,197
+7,896
| +19% | +$849K | 0.04% | 602 |
|
|
2019
Q3 | $3.72M | Sell |
41,301
-8,776
| -18% | -$791K | 0.03% | 746 |
|
|
2019
Q2 | $4.23M | Sell |
50,077
-6,910
| -12% | -$583K | 0.03% | 695 |
|
|
2019
Q1 | $5.02M | Buy |
56,987
+404
| +0.7% | +$35.6K | 0.04% | 611 |
|
|
2018
Q4 | $4.04M | Buy |
56,583
+5,190
| +10% | +$371K | 0.03% | 673 |
|
|
2018
Q3 | $6.32M | Sell |
51,393
-4,330
| -8% | -$532K | 0.04% | 592 |
|
|
2018
Q2 | $5.47M | Sell |
55,723
-2,592
| -4% | -$255K | 0.04% | 658 |
|
|
2018
Q1 | $4.84M | Sell |
58,315
-7,540
| -11% | -$625K | 0.01% | 1033 |
|
|
2017
Q4 | $5.11M | Sell |
65,855
-26,490
| -29% | -$2.06M | 0.01% | 1029 |
|
|
2017
Q3 | $5.66M | Sell |
92,345
-4,140
| -4% | -$254K | 0.01% | 988 |
|
|
2017
Q2 | $4.44M | Buy |
96,485
+7,720
| +9% | +$355K | 0.01% | 1090 |
|
|
2017
Q1 | $3.84M | Buy |
88,765
+6,620
| +8% | +$287K | 0.01% | 1184 |
|
|
2016
Q4 | $3.18M | Sell |
82,145
-6,420
| -7% | -$248K | 0.01% | 1304 |
|
|
2016
Q3 | $4.49M | Sell |
88,565
-10,442
| -11% | -$529K | 0.01% | 1078 |
|
|
2016
Q2 | $4.5M | Sell |
99,007
-17,365
| -15% | -$789K | 0.01% | 1056 |
|
|
2016
Q1 | $4.6M | Sell |
116,372
-29,123
| -20% | -$1.15M | 0.01% | 1032 |
|
|
2015
Q4 | $8.23M | Sell |
145,495
-48,205
| -25% | -$2.73M | 0.02% | 820 |
|
|
2015
Q3 | $7.71M | Sell |
193,700
-37,622
| -16% | -$1.5M | 0.02% | 852 |
|
|
2015
Q2 | $11M | Buy |
231,322
+12,960
| +6% | +$619K | 0.03% | 790 |
|
|
2015
Q1 | $8.67M | Buy |
218,362
+16,145
| +8% | +$641K | 0.02% | 912 |
|
|
2014
Q4 | $4.52M | Buy |
202,217
+8,032
| +4% | +$179K | 0.01% | 1171 |
|
|
2014
Q3 | $3.04M | Buy |
194,185
+4,458
| +2% | +$69.9K | 0.01% | 1455 |
|
|
2014
Q2 | $2.82M | Sell |
189,727
-36,403
| -16% | -$540K | 0.01% | 1509 |
|
|
2014
Q1 | $3.64M | Sell |
226,130
-27,244
| -11% | -$439K | 0.01% | 1316 |
|
|
2013
Q4 | $2.37M | Sell |
253,374
-4,218
| -2% | -$39.4K | 0.01% | 1599 |
|
|
2013
Q3 | $2.92M | Buy |
+257,592
| New | +$2.92M | 0.01% | 1341 |
|